Results 241 to 250 of about 452,625 (299)

The genetic basis of dermatophytosis skin infection susceptibility. [PDF]

Nat Commun
Haapaniemi H, Eghtedarian R, Tervi A, Valliere J, Estonian Biobank Research Team, FinnGen, Abner E, Ollila HM.   +7 more
europepmc   +1 more source

Case Report: Coexistence of a giant borderline phyllodes tumor of the breast and a contralateral fibroadenoma: a challenging case with clinical manifestations and PET-CT imaging mimicking advanced cancer. [PDF]

Front Oncol
Wang XR, Zhang Q, Cui XG.
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Prevention of infections of skin and skin structures

The American Journal of Medicine, 1984
Treatment of nasal carriers of coagulase-positive staphylococci with a wide variety of topical systemic antibiotics suppressed these organisms only during treatment. Treatment of methicillin-sensitive or methicillin-resistant staphylococci with oral rifampin plus cloxacillin, vancomycin, fusidic acid, or trimethoprim-sulfamethoxazole eradicated the ...
L J, Wheat, R B, Kohler, A, White
openaire   +2 more sources

Ceftaroline for complicated skin and skin-structure infections

Expert Opinion on Pharmacotherapy, 2010
A dramatic increase in infections caused by methicillin-resistant Staphylococcus aureus (MRSA) has been observed, in part as a result of the epidemic of community-associated MRSA skin and skin-structure infections (SSSIs). Simultaneously, decreasing sensitivities of S.
Esteban C, Nannini, Martin E, Stryjewski, G Ralph, Corey   +2 more
openaire   +2 more sources

New antibiotics for skin and skin-structure infections

The Lancet Infectious Diseases, 2014
Comment on Tedizolid for 6 days versus linezolid for 10 days for acute bacterial skin and skin-structure infections (ESTABLISH-2): a randomised, double-blind, phase 3, non-inferiority trial. [Lancet Infect Dis. 2014]
Tacconelli, Evelina, Kern, Winfried V
openaire   +4 more sources

Novel antibacterial agents for skin and skin structure infections

Journal of the American Academy of Dermatology, 2004
With the continuing development of clinical drug resistance among bacteria and the advent of resistance to the recently released agents quinupristin-dalfopristin and linezolid, the need for new, effective agents to treat multidrug-resistant gram-positive infections remains important.
Eric S, Schweiger, Jeffrey M, Weinberg
openaire   +2 more sources

Antibiotic treatment of acute bacterial skin and skin structure infections

Current Opinion in Infectious Diseases, 2022
Purpose of review Acute bacterial skin and skin structure infections (ABSSSI) are a leading cause of morbidity, with a considerable variety of clinical presentation and a wide range of etiological pathogens. Of importance, the spread of multidrug-resistant (MDR) strains (i.e.
Russo, Alessandro, Vena, Antonio, Bassetti, Matteo   +2 more
openaire   +3 more sources